All > Diabetes Type 2

Nutritional Ketosis Intervention Referral for Type 2 Diabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Type 2 DiabetesVirta Health - Behavioral
Eligibility
18 - 79
All Sexes
What conditions do you have?
Select

Study Summary

This study is evaluating whether a virtual lifestyle intervention may help improve glucose control in individuals with type 2 diabetes.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
MN-001
2
Tirzepatide Dose 2
3
Tirzepatide

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Group 1: baseline, 3.5 months and 7 months / Group 2: 3.5 months and 7 months

3.5 months
Change in hemoglobin A1c (Percent)
Continuation of referral in Group 1 versus acceptance of referral in Group 2
Month 7
Count of 2-way contacts among subjects
Month 10
Change in hemoglobin A1c
Baseline and 3.5 months
Acceptance/continuation of referral to continuous remote care
Month 5
Acceptance of referral to continuous remote care
Month 10
Change in LDL-cholesterol
Change in fasting glucose
Change in fasting triglyceride/HDL ratio
Change in number and/or doses of anti-hyperglycemic medications • doses of anti-hyperglycemic medications
Month 10
Change in BMI
Month 10
Change in diabetes treatment satisfaction
Change in perceived health status
Month 7
Acceptability of referral
Acceptability of referral over time

Trial Safety

Safety Progress

1 of 3

Similar Trials

2
MN-001
3
Tirzepatide Dose 2
3
Tirzepatide

Trial Design

2 Treatment Groups

Nutritional Ketosis Intervention Referral
1 of 2
CHHS Standard Care - Delayed Referral to Nutritional Ketosis Intervention
1 of 2

Active Control

60 Total Participants · 2 Treatment Groups

Primary Treatment: Nutritional Ketosis Intervention Referral · No Placebo Group · N/A

Nutritional Ketosis Intervention Referral
Behavioral
ActiveComparator Group · 1 Intervention: Virta Health · Intervention Types: Behavioral
CHHS Standard Care - Delayed Referral to Nutritional Ketosis Intervention
Behavioral
ActiveComparator Group · 1 Intervention: Virta Health · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: group 1: baseline, 3.5 months and 7 months / group 2: 3.5 months and 7 months

Who is running the clinical trial?

Colorado Prevention CenterLead Sponsor
9 Previous Clinical Trials
11,208 Total Patients Enrolled
Virta HealthIndustry Sponsor
4 Previous Clinical Trials
50,917 Total Patients Enrolled
Cecilia Low Wang, MDPrincipal InvestigatorCPC Clinical Research
1 Previous Clinical Trials
16 Total Patients Enrolled

Eligibility Criteria

Age 18 - 79 · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top